What is the appropriate conversion ratio from IV Dilaudid (hydromorphone) to a fentanyl patch?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Hydromorphone to Fentanyl Patch Conversion

When converting from IV hydromorphone to transdermal fentanyl patch, use a two-step process: first convert IV hydromorphone to IV morphine equivalent, then use the established conversion table to select the appropriate fentanyl patch strength.

Conversion Algorithm

Step 1: Calculate total daily IV hydromorphone dose

  • Multiply the hourly IV hydromorphone dose by 24 to determine the total daily dose 1

Step 2: Convert IV hydromorphone to IV morphine equivalent

  • Use the equianalgesic ratio where 1.5 mg IV hydromorphone = 10 mg IV morphine 1
  • For example, 6 mg/day IV hydromorphone = 40 mg/day IV morphine 1

Step 3: Select appropriate fentanyl patch strength based on IV morphine equivalent

  • Use the following conversion table from IV morphine to transdermal fentanyl 1:
    • 20 mg/day IV morphine = 25 mcg/h fentanyl patch 1
    • 40 mg/day IV morphine = 50 mcg/h fentanyl patch 1
    • 60 mg/day IV morphine = 75 mcg/h fentanyl patch 1
    • 80 mg/day IV morphine = 100 mcg/h fentanyl patch 1

Step 4: Dose adjustment for cross-tolerance

  • If pain was well-controlled with IV hydromorphone, consider reducing the calculated fentanyl dose by 25-50% to account for incomplete cross-tolerance 1
  • If pain was poorly controlled, use 100% of the calculated equianalgesic dose or consider increasing by 25% 1

Example Calculation

For a patient receiving 2 mg/h IV hydromorphone:

  • Total daily dose: 2 mg/h × 24 h = 48 mg/day IV hydromorphone 1
  • Convert to IV morphine equivalent: 48 mg IV hydromorphone ÷ 1.5 mg × 10 mg = 320 mg/day IV morphine 1
  • Appropriate fentanyl patch: Multiple 100 mcg/h patches (since 80 mg/day IV morphine = 100 mcg/h) 1
  • Consider dose reduction: If pain was well-controlled, reduce by 25-50% (150-240 mcg/h) 1

Important Clinical Considerations

  • Provide breakthrough pain medication during the transition period, particularly during the first 8-24 hours as fentanyl levels reach steady state 1
  • Pain should be relatively well-controlled on short-acting opioids before initiating the fentanyl patch 1
  • Fentanyl patches are NOT recommended for unstable pain requiring frequent dose changes 1
  • Use fentanyl patches only in patients who are opioid-tolerant 1
  • Avoid application of heat (e.g., fever, heat lamps, electric blankets) as it accelerates fentanyl absorption 1

Monitoring and Adjustment

  • Fentanyl patch reaches steady state after 2-3 days; adjust dosage based on breakthrough medication requirements after this period 1
  • The fentanyl patch analgesic duration is usually 72 hours, but some patients require replacement every 48 hours 1
  • Continue breakthrough medication once the patch dose is stabilized 1

Potential Pitfalls

  • The conversion ratio between IV hydromorphone and transdermal fentanyl is not linear and may vary at higher doses 2, 3
  • Studies suggest that at higher doses of opioids, lower conversion ratios may be needed 2, 3
  • Individual patient variability necessitates close monitoring during conversion 1
  • Respiratory depression risk is highest during the first 24-72 hours of transition 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Converting Tramadol to Fentanyl Patch for Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.